Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.45 |
| ▸ | GPR3 | P46089 | 1/20 | 0.45 |
| ▸ | ERN1 | O75460 | 1/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | PDXK | O00764 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3394680 | 0.85 | KDM4E (0.42) | KDM4EGPR3ERN1LOXL2ALDH1A1 | |
| SCHEMBL15045826 | 0.85 | ERN1 (0.46) | KDM4EGPR3ERN1LOXL2ALDH1A1 | |
| SCHEMBL28115761 | 0.85 | KDM4E (0.42) | KDM4EGPR3ERN1LOXL2ALDH1A1 | |
| SCHEMBL11069998 | 0.80 | ERN1 (0.39) | KDM4EGPR3ERN1LOXL2ALDH1A1 | |
| SCHEMBL7850047 | 0.79 | TLR7 (0.43) | KDM4EALDH1A1HPGDHSD17B10GAA | |
| SCHEMBL5013830 | 0.78 | KDM4E (0.47) | KDM4EGPR3ERN1LOXL2ALDH1A1 | |
| SCHEMBL22721625 | 0.78 | KDM4E (0.44) | KDM4EGPR3ERN1LOXL2ALDH1A1 | |
| SCHEMBL22744594 | 0.78 | KDM4E (0.44) | KDM4EGPR3ERN1LOXL2ALDH1A1 | |
| SCHEMBL844114 | 0.78 | MAOA (0.47) | KDM4EGPR3ERN1LOXL2ALDH1A1 | |
| SCHEMBL11064349 | 0.78 | ERN1 (0.44) | KDM4EGPR3ERN1LOXL2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017223409-A1 | DIAGNOSTIC AND THERAPEUTIC METHODS RELATED TO INFLAMMATORY BOWEL DISEASES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-12-28 | — | — | WO | claimed |
| WO-2023009615-A2 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING NEUROLOGICAL INJURY OR NEUROLOGICAL DISORDERS | UNIVERSITY OF CONNECTICUT (US) | 2023-02-02 | — | — | WO | disclosed |
| EP-3996708-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF OPA1 FOR USE IN THE TREATMENT OF CANCER | Università Degli Studi Di Padova (IT) | 2022-05-18 | — | — | EP | disclosed |
| WO-2021008669-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF OPA1 FOR USE IN THE TREATMENT OF CANCER | UNIVERSITA' DEGLI STUDI DI PADOVA (IT) | 2021-01-21 | — | — | WO | disclosed |
| WO-2020198646-A1 | INTRACELLULAR DELIVERY AND MITOCHONDRIAL TARGETING BY FLUORINATION | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2020-10-01 | — | — | WO | disclosed |
| EP-3697389-A1 | SUSTAINED RELEASE FORMULATIONS OFCROCUS SATIVUS | Council of Scientific and Industrial Research (IN) | 2020-08-26 | — | — | EP | disclosed |
| EP-3484496-A1 | METHODS AND COMPOSITION FOR PRODUCING AND USING IMMUNE CELLS AND STEM CELLS FOR CELL-BASED THERAPIES | University of Southern California (US) | 2019-05-22 | — | — | EP | disclosed |
| WO-2019077621-A1 | SUSTAINED RELEASE FORMULATIONS OF CROCUS SATIVUS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2019-04-25 | — | — | WO | disclosed |
| WO-2018148208-A1 | A HIGH THROUGHPUT 3D ASSAY FOR IMMUNE CELL AND DRUG HOMING, MIGRATION AND TUMOR CYTOTOXICITY | CORNING INCORPORATED (US) | 2018-08-16 | — | — | WO | disclosed |
| WO-2018013993-A1 | METHODS AND COMPOSITION FOR PRODUCING AND USING IMMUNE CELLS AND STEM CELLS FOR CELL-BASED THERAPIES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2018-01-18 | — | — | WO | disclosed |
| EP-1348020-A1 | AN OPTICAL METHOD FOR TESTING SENSITIVITY OF CELLS | Medis El Ltd. (IL) | 2003-10-01 | — | — | EP | disclosed |
| WO-2002064758-A9 | AN OPTICAL METHOD FOR TESTING SENSITIVITY OF CELLS | MEDIS EL LTD (IL) | 2003-02-20 | — | — | WO | disclosed |
| WO-2002064758-A1 | AN OPTICAL METHOD FOR TESTING SENSITIVITY OF CELLS | MEDIS EL LTD. (IL) | 2002-08-22 | — | — | WO | disclosed |
| US-6171786-B1 | CONTACTING CELL WITH PHOSPHOINOSITOL-DEPENDENT PHOSPHOLIPASE C INHIBITOR ALONG WITH CYTOTOXIC DRUG | BOARD OF TRUSTEES OF UNIVERSITY OF ILLINOIS | 2001-01-09 | — | — | US | disclosed |
| EP-1023067-A2 | THE USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM FOR THE TREATMENT OF HYPOXIA OR IMPAIRED METABOLIC FUNCTION | Eurogene Limited (GB) | 2000-08-02 | — | — | EP | disclosed |
| WO-1999020260-A2 | THE USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM FOR THE TREATMENT OF HYPOXIA OR IMPAIRED METABOLIC FUNCTION | EUROGENE LIMITED (GB) | 1999-04-29 | — | — | WO | disclosed |
| EP-0804240-A1 | COMPOUNDS FOR PREVENTING MULTIDRUG RESISTANCE IN CANCER CELLS CONTAINING PROTEIN KINASE INHIBITORS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1996025949-A1 | COMPOUNDS FOR PREVENTING MULTIDRUG RESISTANCE IN CANCER CELLS CONTAINING PROTEIN KINASE INHIBITORS | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1996-08-29 | — | — | WO | disclosed |
| US-4447435-A | HYPOTENSIVE AGENTS | THE BOOTS COMPANY PLC (GB) | 1984-05-08 | — | — | US | disclosed |
| US-4442109-A | 3-Methylthiomethyl-and 3-methylsulfinylmethyl-4-quinolinones useful for treating hypertension | THE BOOTS COMPANY LIMITED (GB) | 1984-04-10 | — | — | US | disclosed |